,i #aagth ,,congress #ast ,session ,h4 ,r4 #dfg ,,in ,,the ,,house ,,of ,,representatives ,january #be1 #bjba,mr4 ,gonzalez of ,ohio 7for himself and ,ms4 ,spanberger7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committees on ,ways and ,means1 and ,education and ,labor1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to amend the ,families ,first ,coronavirus ,response ,act and the ,,cares ,act to require group health plans and health insurance issuers offering group or individual health insurance coverage to provide coverage1 without cost sharing1 of certain ,,covid-#ai antibody treatments4 #a4 ,short title ,this ,act may be cited as the ,protecting ,patient ,access to ,lifesaving ,,covid-#ai ,drugs ,act of #bjba4 #b4 ,requiring group health plans and health insurance issuers offering group or individual health insurance coverage to provide coverage1 without cost sharing1 of certain ,,covid-#ai antibody treatments 7a7 ,in general ,section #fjja7;a7 of the ,families ,first ,coronavirus ,response ,act 7#db ,u4,s4,c4 #acbj;b-#e note7 is amended-- 7#a7 in the matter preceding paragraph 7#a71 by inserting 7or1 in the case of items and services described in paragraph 7#c71 beginning on or after the date of the enactment of the ,protecting ,patient ,access to ,lifesaving ,,covid-#ai ,drugs ,act of #bjba7 after this ,act2 and 7#b7 by adding at the end the following new paragraph3 7#c7 ,items consisting of monoclonal antibody infusions 7as specified by the ,secretary7 approved1 cleared1 or otherwise authorized by the ,food and ,drug ,administration needed for the treatment of ,,covid-#ai in individuals with positive ,,covid-#ai test results1 including services for the administration of such items4 4 7b7 ,reimbursement for treatments ,section #cbjb of the ,,cares ,act 7#db ,u4,s4,c4 #bef;b note7 is amended-- 7#a7 in the header1 by inserting and antibody treatments after testing2 7#b7 in subsection 7a71 in the matter preceding paragraph 7#a71 by inserting or antibody treatment1 as applicable1 after diagnostic testing2 and 7#c7 in subsection 7b7-- 7,a7 in the header1 by inserting and antibody treatments after testing2 and 7,b7 in paragraph 7#a7-- 7i7 by inserting or antibody treatment after diagnostic test2 and 7ii7 by inserting or treatment 7including the administration of such treatment7 after such test4